miRNA Sequencing and Assay Market by Product (Library Preparation, Consumables), Technology (Sequencing By Synthesis, Nanopore, Ion Semiconductor Sequencing), End User (Research Institute, Academia, CRO), Region - Global Forecast To 2024
“The miRNA sequencing and assays market is expected to grow at a CAGR of 11.2% during the forecast period.”
The miRNA sequencing and assays market is projected to reach USD 343 million by 2024 from USD 182 million in 2018, at a CAGR of 11.2%. The miRNA sequencing and assays market is driven by various factors such as the advantages of miRNA sequencing over other technologies, increasing research funding for genomics, and the decreasing cost of sequencing. However, the dearth of skilled professionals is expected to limit market growth to a certain extent.
“The sequencing consumables segment held the dominant share of the market in 2018.”
Based on product, the miRNA sequencing & assays market is segmented into library preparation kits and sequencing consumables. Sequencing consumables dominated the market with a larger share in 2018. The large share of this segment can primarily be attributed to the repeat purchases of kits due to their high requirement and the high costs compared to library preparation kits.
“The sequencing by synthesis segment is projected to hold the largest market share of the market during the forecast period.”
By technology, the miRNA sequencing & assays market is segmented into sequencing by synthesis, ion semiconductor sequencing, SOLiD, and Nanopore sequencing. The sequencing by synthesis segment dominated the market with the largest share in 2018 due to the technological advancements in sequencing by synthesis platforms and the reduced cost of sequencing.
“Asia Pacific is expected to record the highest growth rate during the forecast period.”
The APAC miRNA sequencing and assays market, particularly in China, Japan, South Korea, Singapore, and India is expected to witness high growth in the next five years. The rising R&D funding for life sciences research, rapid growth of its life sciences industry, increasing adoption of NGS for miRNA analysis are the major factors driving the growth of this market.
Breakdown of Profiles of Primary Participants:
In-depth interviews were conducted with CEOs, marketing directors, other innovation and technology directors, and executives from various key organizations operating in the microscope software market.
Research Coverage:
The market study covers the miRNA sequencing and assays market across various segments. It aims at estimating the market size and the growth potential of this market across different segments on the basis of products, technologies, and end users. The study also includes an in-depth competitive analysis of the key players in the market; along with their company profiles, key observations related to their product and business offerings, recent developments, and key market strategies.
Key Benefits of Buying the Report:
The report will provide market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall miRNA sequencing and assays market and its subsegments. This report will help the stakeholders to understand the competitive landscape, to gain insights to better position their businesses, and to plan suitable go-to-market strategies. The report will also help the stakeholders to understand the pulse of the market and will provide them with information on key market drivers, restraints, challenges, and opportunities.
The miRNA sequencing and assays market is projected to reach USD 343 million by 2024 from USD 182 million in 2018, at a CAGR of 11.2%. The miRNA sequencing and assays market is driven by various factors such as the advantages of miRNA sequencing over other technologies, increasing research funding for genomics, and the decreasing cost of sequencing. However, the dearth of skilled professionals is expected to limit market growth to a certain extent.
“The sequencing consumables segment held the dominant share of the market in 2018.”
Based on product, the miRNA sequencing & assays market is segmented into library preparation kits and sequencing consumables. Sequencing consumables dominated the market with a larger share in 2018. The large share of this segment can primarily be attributed to the repeat purchases of kits due to their high requirement and the high costs compared to library preparation kits.
“The sequencing by synthesis segment is projected to hold the largest market share of the market during the forecast period.”
By technology, the miRNA sequencing & assays market is segmented into sequencing by synthesis, ion semiconductor sequencing, SOLiD, and Nanopore sequencing. The sequencing by synthesis segment dominated the market with the largest share in 2018 due to the technological advancements in sequencing by synthesis platforms and the reduced cost of sequencing.
“Asia Pacific is expected to record the highest growth rate during the forecast period.”
The APAC miRNA sequencing and assays market, particularly in China, Japan, South Korea, Singapore, and India is expected to witness high growth in the next five years. The rising R&D funding for life sciences research, rapid growth of its life sciences industry, increasing adoption of NGS for miRNA analysis are the major factors driving the growth of this market.
Breakdown of Profiles of Primary Participants:
In-depth interviews were conducted with CEOs, marketing directors, other innovation and technology directors, and executives from various key organizations operating in the microscope software market.
- By Company Type: Tier 1: 48%, Tier 2: 34%, and Tier 3: 18%
- By Designation: C-level Executives: 42%, Directors: 14%, and Others: 18%
- By Region: North America: 38%, Europe: 25%, APAC: 30%, and RoW: 7%
Research Coverage:
The market study covers the miRNA sequencing and assays market across various segments. It aims at estimating the market size and the growth potential of this market across different segments on the basis of products, technologies, and end users. The study also includes an in-depth competitive analysis of the key players in the market; along with their company profiles, key observations related to their product and business offerings, recent developments, and key market strategies.
Key Benefits of Buying the Report:
The report will provide market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall miRNA sequencing and assays market and its subsegments. This report will help the stakeholders to understand the competitive landscape, to gain insights to better position their businesses, and to plan suitable go-to-market strategies. The report will also help the stakeholders to understand the pulse of the market and will provide them with information on key market drivers, restraints, challenges, and opportunities.
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.3.2 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY
1.5 STAKEHOLDERS
1.6 LIMITATIONS
2 RESEARCH METHODOLOGY
2.1 RESEARCH APPROACH
2.1.1 SECONDARY RESEARCH
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY RESEARCH
2.1.2.1 Key data from primary sources
2.1.2.2 Break down of primaries
2.1.2.3 Key industry insights
2.2 MARKET SIZE ESTIMATION
2.3 DATA TRIANGULATION APPROACH
2.4 ASSUMPTIONS FOR THE STUDY
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 MIRNA SEQUENCING & ASSAYS MARKET OVERVIEW
4.2 MIRNA SEQUENCING & ASSAYS MARKET, BY TECHNOLOGY (2016–2024)
4.3 NORTH AMERICA: MIRNA SEQUENCING & ASSAYS MARKET, BY PRODUCT (2018)
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 MARKET DRIVERS
5.2.1.1 Advantages of miRNA sequencing over other technologies
5.2.1.2 Increasing research funding for genomics
5.2.1.3 Decreasing cost of sequencing
5.2.2 MARKET OPPORTUNITIES
5.2.2.1 Increasing focus on miRNA biomarker discovery
5.2.3 MARKET CHALLENGES
5.2.3.1 Dearth of skilled professionals
6 MIRNA SEQUENCING AND ASSAYS MARKET, BY PRODUCT
6.1 INTRODUCTION
6.2 SEQUENCING CONSUMABLES
6.2.1 INCREASING DEMAND FOR MIRNA SEQUENCING IS BOOSTING THE ADOPTION OF SEQUENCING CONSUMABLES
6.3 LIBRARY PREPARATION KITS
6.3.1 LIBRARY PREPARATION KITS SEGMENT TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD
7 MIRNA SEQUENCING AND ASSAYS MARKET, BY TECHNOLOGY
7.1 INTRODUCTION
7.2 SEQUENCING BY SYNTHESIS
7.2.1 SEQUENCING BY SYNTHESIS SEGMENT ACCOUNTED FOR THE LARGEST MARKET SHARE IN 2018
7.3 ION SEMICONDUCTOR SEQUENCING
7.3.1 PLATFORMS DEVELOPED USING THIS TECHNOLOGY ARE LOW-COST INSTRUMENTS AND POSSESS HIGH-THROUGHPUT CAPABILITIES
7.4 SEQUENCING BY OLIGONUCLEOTIDE LIGATION AND DETECTION
7.4.1 SOLID SEQUENCING OFFERS ACCURATE SEQUENCING OF SHORT READS
7.5 NANOPORE SEQUENCING
7.5.1 NANOPORE SEQUENCING SEGMENT TO WITNESS THE HIGHEST GROWTH DURING THE FORECAST PERIOD
8 MIRNA SEQUENCING AND ASSAYS MARKET, BY END USER
8.1 INTRODUCTION
8.2 RESEARCH AND ACADEMIC INSTITUTES
8.2.1 RESEARCH AND ACADEMIC INSTITUTES SEGMENT TO DOMINATE THIS SEGMENT
8.3 CONTRACT RESEARCH ORGANIZATIONS
8.3.1 CONTRACT RESEARCH ORGANIZATIONS SUCH AS GENOMICS SERVICES COMPANIES TO GROW AT HIGHEST CAGR'
9 MIRNA SEQUENCING AND ASSAYS MARKET, BY REGION
9.1 INTRODUCTION
9.2 NORTH AMERICA
9.2.1 US
9.2.1.1 US dominates the north american miRNA sequencing and assays market, due to the favorable funding scenario for research and strong presence of key market players
9.2.2 CANADA
9.2.2.1 Increase in genomics research to drive the adoption of mirna sequencing in Canada
9.3 EUROPE
9.3.1 GERMANY
9.3.1.1 Growth of the genomics market to drive the growth of the market growth
9.3.2 UK
9.3.2.1 Government initiatives in genomics to drive the market for mirna sequencing
9.3.3 ROE
9.4 ASIA PACIFIC
9.5 REST OF THE WORLD
10 COMPETITIVE LANDSCAPE
10.1 OVERVIEW
10.2 VENDOR BENCHMARKING
10.3 COMPETITIVE LEADERSHIP MAPPING
10.3.1 VISIONARY LEADERS
10.3.2 INNOVATORS
10.3.3 DYNAMIC DIFFERENTIATORS
10.3.4 EMERGING COMPANIES
10.4 MARKET RANKING ANALYSIS, 2017
10.5 COMPETITIVE SITUATION AND TRENDS
10.5.1 COLLABORATIONS, PARTNERSHIPS, AND AGREEMENTS
10.5.2 PRODUCT LAUNCHES
10.5.3 ACQUISITIONS
11 COMPANY PROFILES
(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*
11.1 ILLUMINA, INC.
11.2 THERMO FISHER SCIENTIFIC
11.3 QIAGEN
11.4 PERKINELMER, INC.
11.5 TAKARA BIO, INC.
11.6 NEW ENGLAND BIOLABS, INC.
11.7 NORGEN BIOTEK CORPORATION
11.8 TRILINK BIOTECHNOLOGIES
11.9 LEXOGEN
11.10 OXFORD NANOPORE TECHNOLOGIES
*Details on MarketsandMarkets view, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments might not be captured in case of unlisted companies.
12 APPENDIX
12.1 DISCUSSION GUIDE
12.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
12.3 AVAILABLE CUSTOMIZATIONS
12.4 RELATED REPORTS
12.5 AUTHOR DETAILS
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.3.2 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY
1.5 STAKEHOLDERS
1.6 LIMITATIONS
2 RESEARCH METHODOLOGY
2.1 RESEARCH APPROACH
2.1.1 SECONDARY RESEARCH
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY RESEARCH
2.1.2.1 Key data from primary sources
2.1.2.2 Break down of primaries
2.1.2.3 Key industry insights
2.2 MARKET SIZE ESTIMATION
2.3 DATA TRIANGULATION APPROACH
2.4 ASSUMPTIONS FOR THE STUDY
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 MIRNA SEQUENCING & ASSAYS MARKET OVERVIEW
4.2 MIRNA SEQUENCING & ASSAYS MARKET, BY TECHNOLOGY (2016–2024)
4.3 NORTH AMERICA: MIRNA SEQUENCING & ASSAYS MARKET, BY PRODUCT (2018)
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 MARKET DRIVERS
5.2.1.1 Advantages of miRNA sequencing over other technologies
5.2.1.2 Increasing research funding for genomics
5.2.1.3 Decreasing cost of sequencing
5.2.2 MARKET OPPORTUNITIES
5.2.2.1 Increasing focus on miRNA biomarker discovery
5.2.3 MARKET CHALLENGES
5.2.3.1 Dearth of skilled professionals
6 MIRNA SEQUENCING AND ASSAYS MARKET, BY PRODUCT
6.1 INTRODUCTION
6.2 SEQUENCING CONSUMABLES
6.2.1 INCREASING DEMAND FOR MIRNA SEQUENCING IS BOOSTING THE ADOPTION OF SEQUENCING CONSUMABLES
6.3 LIBRARY PREPARATION KITS
6.3.1 LIBRARY PREPARATION KITS SEGMENT TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD
7 MIRNA SEQUENCING AND ASSAYS MARKET, BY TECHNOLOGY
7.1 INTRODUCTION
7.2 SEQUENCING BY SYNTHESIS
7.2.1 SEQUENCING BY SYNTHESIS SEGMENT ACCOUNTED FOR THE LARGEST MARKET SHARE IN 2018
7.3 ION SEMICONDUCTOR SEQUENCING
7.3.1 PLATFORMS DEVELOPED USING THIS TECHNOLOGY ARE LOW-COST INSTRUMENTS AND POSSESS HIGH-THROUGHPUT CAPABILITIES
7.4 SEQUENCING BY OLIGONUCLEOTIDE LIGATION AND DETECTION
7.4.1 SOLID SEQUENCING OFFERS ACCURATE SEQUENCING OF SHORT READS
7.5 NANOPORE SEQUENCING
7.5.1 NANOPORE SEQUENCING SEGMENT TO WITNESS THE HIGHEST GROWTH DURING THE FORECAST PERIOD
8 MIRNA SEQUENCING AND ASSAYS MARKET, BY END USER
8.1 INTRODUCTION
8.2 RESEARCH AND ACADEMIC INSTITUTES
8.2.1 RESEARCH AND ACADEMIC INSTITUTES SEGMENT TO DOMINATE THIS SEGMENT
8.3 CONTRACT RESEARCH ORGANIZATIONS
8.3.1 CONTRACT RESEARCH ORGANIZATIONS SUCH AS GENOMICS SERVICES COMPANIES TO GROW AT HIGHEST CAGR'
9 MIRNA SEQUENCING AND ASSAYS MARKET, BY REGION
9.1 INTRODUCTION
9.2 NORTH AMERICA
9.2.1 US
9.2.1.1 US dominates the north american miRNA sequencing and assays market, due to the favorable funding scenario for research and strong presence of key market players
9.2.2 CANADA
9.2.2.1 Increase in genomics research to drive the adoption of mirna sequencing in Canada
9.3 EUROPE
9.3.1 GERMANY
9.3.1.1 Growth of the genomics market to drive the growth of the market growth
9.3.2 UK
9.3.2.1 Government initiatives in genomics to drive the market for mirna sequencing
9.3.3 ROE
9.4 ASIA PACIFIC
9.5 REST OF THE WORLD
10 COMPETITIVE LANDSCAPE
10.1 OVERVIEW
10.2 VENDOR BENCHMARKING
10.3 COMPETITIVE LEADERSHIP MAPPING
10.3.1 VISIONARY LEADERS
10.3.2 INNOVATORS
10.3.3 DYNAMIC DIFFERENTIATORS
10.3.4 EMERGING COMPANIES
10.4 MARKET RANKING ANALYSIS, 2017
10.5 COMPETITIVE SITUATION AND TRENDS
10.5.1 COLLABORATIONS, PARTNERSHIPS, AND AGREEMENTS
10.5.2 PRODUCT LAUNCHES
10.5.3 ACQUISITIONS
11 COMPANY PROFILES
(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*
11.1 ILLUMINA, INC.
11.2 THERMO FISHER SCIENTIFIC
11.3 QIAGEN
11.4 PERKINELMER, INC.
11.5 TAKARA BIO, INC.
11.6 NEW ENGLAND BIOLABS, INC.
11.7 NORGEN BIOTEK CORPORATION
11.8 TRILINK BIOTECHNOLOGIES
11.9 LEXOGEN
11.10 OXFORD NANOPORE TECHNOLOGIES
*Details on MarketsandMarkets view, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments might not be captured in case of unlisted companies.
12 APPENDIX
12.1 DISCUSSION GUIDE
12.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
12.3 AVAILABLE CUSTOMIZATIONS
12.4 RELATED REPORTS
12.5 AUTHOR DETAILS
LIST OF TABLES
TABLE 1 MIRNA SEQUENCING AND ASSAYS MARKET, BY PRODUCT
2016–2024 (USD MILLION)
TABLE 2 MIRNA SEQUENCING CONSUMABLES MARKET, BY REGION, 2016–2024 (USD MILLION)
TABLE 3 NORTH AMERICA: MIRNA SEQUENCING CONSUMABLES MARKET, BY COUNTRY, 2016–2024 (USD MILLION)
TABLE 4 EUROPE: MIRNA SEQUENCING CONSUMABLES MARKET, BY COUNTRY, 2016–2024 (USD MILLION)
TABLE 5 MIRNA LIBRARY PREPARATION KITS MARKET, BY REGION, 2016–2024 (USD MILLION)
TABLE 6 NORTH AMERICA: MIRNA LIBRARY PREPARATION KITS MARKET, BY COUNTRY, 2016–2024 (USD MILLION)
TABLE 7 EUROPE: MIRNA LIBRARY PREPARATION KITS MARKET, BY COUNTRY, 2016–2024 (USD MILLION)
TABLE 8 MIRNA SEQUENCING AND ASSAYS MARKET, BY TECHNOLOGY, 2016–2024 (USD MILLION)
TABLE 9 MIRNA SEQUENCING AND ASSAYS MARKET FOR SEQUENCING BY SYNTHESIS, BY REGION, 2016–2024 (USD MILLION)
TABLE 10 NORTH AMERICA: MIRNA SEQUENCING AND ASSAYS MARKET FOR SEQUENCING BY SYNTHESIS, BY COUNTRY, 2016–2024 (USD MILLION)
TABLE 11 EUROPE: MIRNA SEQUENCING AND ASSAYS MARKET FOR SEQUENCING BY SYNTHESIS, BY COUNTRY, 2016–2024 (USD MILLION)
TABLE 12 MIRNA SEQUENCING AND ASSAYS MARKET FOR ION SEMICONDUCTOR SEQUENCING, BY REGION, 2016–2024 (USD MILLION)
TABLE 13 NORTH AMERICA: MIRNA SEQUENCING AND ASSAYS MARKET FOR ION SEMICONDUCTOR SEQUENCING, BY COUNTRY, 2016–2024 (USD MILLION)
TABLE 14 EUROPE: MIRNA SEQUENCING AND ASSAYS MARKET FOR ION SEMICONDUCTOR SEQUENCING, BY COUNTRY, 2016–2024 (USD MILLION)
TABLE 15 MIRNA SEQUENCING AND ASSAYS MARKET FOR SOLID SEQUENCING, BY REGION, 2016–2024 (USD THOUSAND)
TABLE 16 NORTH AMERICA: MIRNA SEQUENCING AND ASSAYS MARKET FOR SOLID SEQUENCING, BY COUNTRY, 2016–2024 (USD MILLION)
TABLE 17 EUROPE: MIRNA SEQUENCING AND ASSAYS MARKET FOR SOLID SEQUENCING, BY COUNTRY, 2016–2024 (USD MILLION)
TABLE 18 MIRNA SEQUENCING AND ASSAYS MARKET FOR NANOPORE SEQUENCING, BY REGION, 2016–2024 (USD THOUSAND)
TABLE 19 NORTH AMERICA: MIRNA SEQUENCING AND ASSAYS MARKET FOR NANOPORE SEQUENCING, BY COUNTRY, 2016–2024 (USD THOUSAND)
TABLE 20 EUROPE: MIRNA SEQUENCING AND ASSAYS MARKET FOR NANOPORE SEQUENCING, BY COUNTRY, 2016–2024 (USD THOUSAND)
TABLE 21 MIRNA SEQUENCING AND ASSAYS MARKET, BY END USER, 2016–2024 (USD MILLION)
TABLE 22 MIRNA SEQUENCING AND ASSAYS MARKET FOR RESEARCH AND ACADEMIC INSTITUTES, BY REGION, 2016–2024 (USD MILLION)
TABLE 23 NORTH AMERICA: MIRNA SEQUENCING AND ASSAYS MARKET FOR RESEARCH AND ACADEMIC INSTITUTES, BY COUNTRY, 2016–2024 (USD MILLION)
TABLE 24 EUROPE: MIRNA SEQUENCING AND ASSAYS MARKET FOR RESEARCH AND ACADEMIC INSTITUTES, BY COUNTRY, 2016–2024 (USD MILLION)
TABLE 25 MIRNA SEQUENCING AND ASSAYS MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2016–2024 (USD MILLION)
TABLE 26 NORTH AMERICA: MIRNA SEQUENCING AND ASSAYS MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2016–2024 (USD MILLION)
TABLE 27 EUROPE: MIRNA SEQUENCING AND ASSAYS MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2016–2024 (USD MILLION)
TABLE 28 MIRNA SEQUENCING AND ASSAYS MARKET, BY REGION, 2016–2024 (USD MILLION)
TABLE 29 MIRNA SEQUENCING AND ASSAYS MARKET, BY COUNTRY, 2016–2024 (USD MILLION)
TABLE 30 NORTH AMERICA: MIRNA SEQUENCING AND ASSAYS MARKET, BY COUNTRY, 2016–2024 (USD MILLION)
TABLE 31 NORTH AMERICA: MIRNA SEQUENCING AND ASSAYS MARKET, BY PRODUCT, 2016–2024 (USD MILLION)
TABLE 32 NORTH AMERICA: MIRNA SEQUENCING AND ASSAYS MARKET, BY TECHNOLOGY, 2016–2024 (USD MILLION)
TABLE 33 NORTH AMERICA: MIRNA SEQUENCING AND ASSAYS MARKET, BY END USER, 2016–2024 (USD MILLION)
TABLE 34 US: MIRNA SEQUENCING AND ASSAYS MARKET, BY PRODUCT, 2016–2024 (USD MILLION)
TABLE 35 US: MIRNA SEQUENCING AND ASSAYS MARKET, BY TECHNOLOGY, 2016–2024 (USD MILLION)
TABLE 36 US: MIRNA SEQUENCING AND ASSAYS MARKET, BY END USER, 2016–2024 (USD MILLION)
TABLE 37 CANADA: MIRNA SEQUENCING AND ASSAYS MARKET, BY PRODUCT, 2016–2024 (USD MILLION)
TABLE 38 CANADA: MIRNA SEQUENCING AND ASSAYS MARKET, BY TECHNOLOGY, 2016–2024 (USD THOUSAND)
TABLE 39 CANADA: MIRNA SEQUENCING AND ASSAYS MARKET, BY END USER, 2016–2024 (USD MILLION)
TABLE 40 EUROPE: MIRNA SEQUENCING AND ASSAYS MARKET, BY COUNTRY, 2016–2024 (USD MILLION)
TABLE 41 EUROPE: MIRNA SEQUENCING AND ASSAYS MARKET, BY PRODUCT, 2016–2024 (USD MILLION)
TABLE 42 EUROPE: MIRNA SEQUENCING AND ASSAYS MARKET, BY TECHNOLOGY, 2016–2024 (USD MILLION)
TABLE 43 EUROPE: MIRNA SEQUENCING AND ASSAYS MARKET, BY END USER, 2016–2024 (USD MILLION)
TABLE 44 GERMANY: MIRNA SEQUENCING AND ASSAYS MARKET, BY PRODUCT, 2016–2024 (USD MILLION)
TABLE 45 GERMANY: MIRNA SEQUENCING AND ASSAYS MARKET, BY TECHNOLOGY, 2016–2024 (USD MILLION)
TABLE 46 GERMANY: MIRNA SEQUENCING AND ASSAYS MARKET, BY END USER, 2016–2024 (USD MILLION)
TABLE 47 UK: MIRNA SEQUENCING AND ASSAYS MARKET, BY PRODUCT, 2016–2024 (USD MILLION)
TABLE 48 UK: MIRNA SEQUENCING AND ASSAYS MARKET, BY TECHNOLOGY, 2016–2024 (USD MILLION)
TABLE 49 UK: MIRNA SEQUENCING AND ASSAYS MARKET, BY END USER, 2016–2024 (USD MILLION)
TABLE 50 ROE: MIRNA SEQUENCING AND ASSAYS MARKET, BY PRODUCT, 2016–2024 (USD MILLION)
TABLE 51 ROE: MIRNA SEQUENCING AND ASSAYS MARKET, BY TECHNOLOGY, 2016–2024 (USD MILLION)
TABLE 52 ROE: MIRNA SEQUENCING AND ASSAYS MARKET, BY END USER, 2016–2024 (USD MILLION)
TABLE 53 APAC: MIRNA SEQUENCING AND ASSAYS MARKET, BY PRODUCT, 2016–2024 (USD MILLION)
TABLE 54 APAC: MIRNA SEQUENCING AND ASSAYS MARKET, BY TECHNOLOGY, 2016–2024 (USD MILLION)
TABLE 55 APAC: MIRNA SEQUENCING AND ASSAYS MARKET, BY END USER, 2016–2024 (USD MILLION)
TABLE 56 ROW: MIRNA SEQUENCING AND ASSAYS MARKET, BY PRODUCT, 2016–2024 (USD MILLION)
TABLE 57 ROW: MIRNA SEQUENCING AND ASSAYS MARKET, BY TECHNOLOGY, 2016–2024 (USD THOUSANDS)
TABLE 58 ROW: MIRNA SEQUENCING AND ASSAYS MARKET, BY END USER, 2016–2024 (USD MILLION)
TABLE 59 COLLABORATIONS, PARTNERSHIPS, AND AGREEMENTS, 2016–2018
TABLE 60 PRODUCT LAUNCHES, 2016–2018
TABLE 61 ACQUISITIONS, 2016-2018
TABLE 1 MIRNA SEQUENCING AND ASSAYS MARKET, BY PRODUCT
2016–2024 (USD MILLION)
TABLE 2 MIRNA SEQUENCING CONSUMABLES MARKET, BY REGION, 2016–2024 (USD MILLION)
TABLE 3 NORTH AMERICA: MIRNA SEQUENCING CONSUMABLES MARKET, BY COUNTRY, 2016–2024 (USD MILLION)
TABLE 4 EUROPE: MIRNA SEQUENCING CONSUMABLES MARKET, BY COUNTRY, 2016–2024 (USD MILLION)
TABLE 5 MIRNA LIBRARY PREPARATION KITS MARKET, BY REGION, 2016–2024 (USD MILLION)
TABLE 6 NORTH AMERICA: MIRNA LIBRARY PREPARATION KITS MARKET, BY COUNTRY, 2016–2024 (USD MILLION)
TABLE 7 EUROPE: MIRNA LIBRARY PREPARATION KITS MARKET, BY COUNTRY, 2016–2024 (USD MILLION)
TABLE 8 MIRNA SEQUENCING AND ASSAYS MARKET, BY TECHNOLOGY, 2016–2024 (USD MILLION)
TABLE 9 MIRNA SEQUENCING AND ASSAYS MARKET FOR SEQUENCING BY SYNTHESIS, BY REGION, 2016–2024 (USD MILLION)
TABLE 10 NORTH AMERICA: MIRNA SEQUENCING AND ASSAYS MARKET FOR SEQUENCING BY SYNTHESIS, BY COUNTRY, 2016–2024 (USD MILLION)
TABLE 11 EUROPE: MIRNA SEQUENCING AND ASSAYS MARKET FOR SEQUENCING BY SYNTHESIS, BY COUNTRY, 2016–2024 (USD MILLION)
TABLE 12 MIRNA SEQUENCING AND ASSAYS MARKET FOR ION SEMICONDUCTOR SEQUENCING, BY REGION, 2016–2024 (USD MILLION)
TABLE 13 NORTH AMERICA: MIRNA SEQUENCING AND ASSAYS MARKET FOR ION SEMICONDUCTOR SEQUENCING, BY COUNTRY, 2016–2024 (USD MILLION)
TABLE 14 EUROPE: MIRNA SEQUENCING AND ASSAYS MARKET FOR ION SEMICONDUCTOR SEQUENCING, BY COUNTRY, 2016–2024 (USD MILLION)
TABLE 15 MIRNA SEQUENCING AND ASSAYS MARKET FOR SOLID SEQUENCING, BY REGION, 2016–2024 (USD THOUSAND)
TABLE 16 NORTH AMERICA: MIRNA SEQUENCING AND ASSAYS MARKET FOR SOLID SEQUENCING, BY COUNTRY, 2016–2024 (USD MILLION)
TABLE 17 EUROPE: MIRNA SEQUENCING AND ASSAYS MARKET FOR SOLID SEQUENCING, BY COUNTRY, 2016–2024 (USD MILLION)
TABLE 18 MIRNA SEQUENCING AND ASSAYS MARKET FOR NANOPORE SEQUENCING, BY REGION, 2016–2024 (USD THOUSAND)
TABLE 19 NORTH AMERICA: MIRNA SEQUENCING AND ASSAYS MARKET FOR NANOPORE SEQUENCING, BY COUNTRY, 2016–2024 (USD THOUSAND)
TABLE 20 EUROPE: MIRNA SEQUENCING AND ASSAYS MARKET FOR NANOPORE SEQUENCING, BY COUNTRY, 2016–2024 (USD THOUSAND)
TABLE 21 MIRNA SEQUENCING AND ASSAYS MARKET, BY END USER, 2016–2024 (USD MILLION)
TABLE 22 MIRNA SEQUENCING AND ASSAYS MARKET FOR RESEARCH AND ACADEMIC INSTITUTES, BY REGION, 2016–2024 (USD MILLION)
TABLE 23 NORTH AMERICA: MIRNA SEQUENCING AND ASSAYS MARKET FOR RESEARCH AND ACADEMIC INSTITUTES, BY COUNTRY, 2016–2024 (USD MILLION)
TABLE 24 EUROPE: MIRNA SEQUENCING AND ASSAYS MARKET FOR RESEARCH AND ACADEMIC INSTITUTES, BY COUNTRY, 2016–2024 (USD MILLION)
TABLE 25 MIRNA SEQUENCING AND ASSAYS MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2016–2024 (USD MILLION)
TABLE 26 NORTH AMERICA: MIRNA SEQUENCING AND ASSAYS MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2016–2024 (USD MILLION)
TABLE 27 EUROPE: MIRNA SEQUENCING AND ASSAYS MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2016–2024 (USD MILLION)
TABLE 28 MIRNA SEQUENCING AND ASSAYS MARKET, BY REGION, 2016–2024 (USD MILLION)
TABLE 29 MIRNA SEQUENCING AND ASSAYS MARKET, BY COUNTRY, 2016–2024 (USD MILLION)
TABLE 30 NORTH AMERICA: MIRNA SEQUENCING AND ASSAYS MARKET, BY COUNTRY, 2016–2024 (USD MILLION)
TABLE 31 NORTH AMERICA: MIRNA SEQUENCING AND ASSAYS MARKET, BY PRODUCT, 2016–2024 (USD MILLION)
TABLE 32 NORTH AMERICA: MIRNA SEQUENCING AND ASSAYS MARKET, BY TECHNOLOGY, 2016–2024 (USD MILLION)
TABLE 33 NORTH AMERICA: MIRNA SEQUENCING AND ASSAYS MARKET, BY END USER, 2016–2024 (USD MILLION)
TABLE 34 US: MIRNA SEQUENCING AND ASSAYS MARKET, BY PRODUCT, 2016–2024 (USD MILLION)
TABLE 35 US: MIRNA SEQUENCING AND ASSAYS MARKET, BY TECHNOLOGY, 2016–2024 (USD MILLION)
TABLE 36 US: MIRNA SEQUENCING AND ASSAYS MARKET, BY END USER, 2016–2024 (USD MILLION)
TABLE 37 CANADA: MIRNA SEQUENCING AND ASSAYS MARKET, BY PRODUCT, 2016–2024 (USD MILLION)
TABLE 38 CANADA: MIRNA SEQUENCING AND ASSAYS MARKET, BY TECHNOLOGY, 2016–2024 (USD THOUSAND)
TABLE 39 CANADA: MIRNA SEQUENCING AND ASSAYS MARKET, BY END USER, 2016–2024 (USD MILLION)
TABLE 40 EUROPE: MIRNA SEQUENCING AND ASSAYS MARKET, BY COUNTRY, 2016–2024 (USD MILLION)
TABLE 41 EUROPE: MIRNA SEQUENCING AND ASSAYS MARKET, BY PRODUCT, 2016–2024 (USD MILLION)
TABLE 42 EUROPE: MIRNA SEQUENCING AND ASSAYS MARKET, BY TECHNOLOGY, 2016–2024 (USD MILLION)
TABLE 43 EUROPE: MIRNA SEQUENCING AND ASSAYS MARKET, BY END USER, 2016–2024 (USD MILLION)
TABLE 44 GERMANY: MIRNA SEQUENCING AND ASSAYS MARKET, BY PRODUCT, 2016–2024 (USD MILLION)
TABLE 45 GERMANY: MIRNA SEQUENCING AND ASSAYS MARKET, BY TECHNOLOGY, 2016–2024 (USD MILLION)
TABLE 46 GERMANY: MIRNA SEQUENCING AND ASSAYS MARKET, BY END USER, 2016–2024 (USD MILLION)
TABLE 47 UK: MIRNA SEQUENCING AND ASSAYS MARKET, BY PRODUCT, 2016–2024 (USD MILLION)
TABLE 48 UK: MIRNA SEQUENCING AND ASSAYS MARKET, BY TECHNOLOGY, 2016–2024 (USD MILLION)
TABLE 49 UK: MIRNA SEQUENCING AND ASSAYS MARKET, BY END USER, 2016–2024 (USD MILLION)
TABLE 50 ROE: MIRNA SEQUENCING AND ASSAYS MARKET, BY PRODUCT, 2016–2024 (USD MILLION)
TABLE 51 ROE: MIRNA SEQUENCING AND ASSAYS MARKET, BY TECHNOLOGY, 2016–2024 (USD MILLION)
TABLE 52 ROE: MIRNA SEQUENCING AND ASSAYS MARKET, BY END USER, 2016–2024 (USD MILLION)
TABLE 53 APAC: MIRNA SEQUENCING AND ASSAYS MARKET, BY PRODUCT, 2016–2024 (USD MILLION)
TABLE 54 APAC: MIRNA SEQUENCING AND ASSAYS MARKET, BY TECHNOLOGY, 2016–2024 (USD MILLION)
TABLE 55 APAC: MIRNA SEQUENCING AND ASSAYS MARKET, BY END USER, 2016–2024 (USD MILLION)
TABLE 56 ROW: MIRNA SEQUENCING AND ASSAYS MARKET, BY PRODUCT, 2016–2024 (USD MILLION)
TABLE 57 ROW: MIRNA SEQUENCING AND ASSAYS MARKET, BY TECHNOLOGY, 2016–2024 (USD THOUSANDS)
TABLE 58 ROW: MIRNA SEQUENCING AND ASSAYS MARKET, BY END USER, 2016–2024 (USD MILLION)
TABLE 59 COLLABORATIONS, PARTNERSHIPS, AND AGREEMENTS, 2016–2018
TABLE 60 PRODUCT LAUNCHES, 2016–2018
TABLE 61 ACQUISITIONS, 2016-2018
LIST OF FIGURES
FIGURE 1 MIRNA SEQUENCING AND ASSAYS MARKET
FIGURE 2 RESEARCH DESIGN
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATIONS, AND REGION
FIGURE 4 BOTTOM-UP APPROACH
FIGURE 5 TOP-DOWN APPROACH
FIGURE 6 DATA TRIANGULATION METHODOLOGY
FIGURE 7 MIRNA SEQUENCING & ASSAYS MARKET, BY PRODUCT, 2018 VS. 2024 (USD MILLION)
FIGURE 8 MIRNA SEQUENCING & ASSAYS MARKET, BY TECHNOLOGY, 2018 VS. 2024 (USD MILLION)
FIGURE 9 MIRNA SEQUENCING & ASSAYS MARKET, BY END USER, 2018 VS. 2024 (USD MILLION)
FIGURE 10 GEOGRAPHICAL SNAPSHOT OF THE MIRNA SEQUENCING & ASSAYS MARKET
FIGURE 11 INCREASING RESEARCH ACTIVITIES IN THE LIFE SCIENCE INDUSTRY —A KEY DRIVER FOR MARKET GROWTH
FIGURE 12 SEQUENCING BY SYNTHESIS TO CONTINUE TO DOMINATE THE MIRNA SEQUENCING AND ASSAYS MARKET IN 2024
FIGURE 13 SEQUENCING CONSUMABLES ACCOUNTED FOR THE LARGEST SHARE OF THE NORTH AMERICAN MIRNA SEQUENCING AND ASSAYS MARKET IN 2018
FIGURE 14 MIRNA SEQUENCING AND ASSAYS MARKET: DRIVERS, OPPORTUNITIES, AND CHALLENGES
FIGURE 15 COST PER GENOME, 2008–2017
FIGURE 16 NORTH AMERICA: MIRNA SEQUENCING AND ASSAYS MARKET SNAPSHOT
FIGURE 17 EUROPE: MIRNA SEQUENCING AND ASSAYS MARKET SNAPSHOT
FIGURE 18 MIRNA SEQUENCING AND ASSAYS MARKET (GLOBAL), COMPETITIVE LEADERSHIP MAPPING, 2017
FIGURE 19 RANK OF COMPANIES IN THE GLOBAL MIRNA SEQUENCING AND ASSAYS MARKET, 2017
FIGURE 20 ILLUMINA: COMPANY SNAPSHOT
FIGURE 21 THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT
FIGURE 22 QIAGEN N.V: COMPANY SNAPSHOT
FIGURE 23 PERKINELMER, INC.: COMPANY SNAPSHOT
FIGURE 24 TAKARA BIO, INC.: COMPANY SNAPSHOT
FIGURE 1 MIRNA SEQUENCING AND ASSAYS MARKET
FIGURE 2 RESEARCH DESIGN
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATIONS, AND REGION
FIGURE 4 BOTTOM-UP APPROACH
FIGURE 5 TOP-DOWN APPROACH
FIGURE 6 DATA TRIANGULATION METHODOLOGY
FIGURE 7 MIRNA SEQUENCING & ASSAYS MARKET, BY PRODUCT, 2018 VS. 2024 (USD MILLION)
FIGURE 8 MIRNA SEQUENCING & ASSAYS MARKET, BY TECHNOLOGY, 2018 VS. 2024 (USD MILLION)
FIGURE 9 MIRNA SEQUENCING & ASSAYS MARKET, BY END USER, 2018 VS. 2024 (USD MILLION)
FIGURE 10 GEOGRAPHICAL SNAPSHOT OF THE MIRNA SEQUENCING & ASSAYS MARKET
FIGURE 11 INCREASING RESEARCH ACTIVITIES IN THE LIFE SCIENCE INDUSTRY —A KEY DRIVER FOR MARKET GROWTH
FIGURE 12 SEQUENCING BY SYNTHESIS TO CONTINUE TO DOMINATE THE MIRNA SEQUENCING AND ASSAYS MARKET IN 2024
FIGURE 13 SEQUENCING CONSUMABLES ACCOUNTED FOR THE LARGEST SHARE OF THE NORTH AMERICAN MIRNA SEQUENCING AND ASSAYS MARKET IN 2018
FIGURE 14 MIRNA SEQUENCING AND ASSAYS MARKET: DRIVERS, OPPORTUNITIES, AND CHALLENGES
FIGURE 15 COST PER GENOME, 2008–2017
FIGURE 16 NORTH AMERICA: MIRNA SEQUENCING AND ASSAYS MARKET SNAPSHOT
FIGURE 17 EUROPE: MIRNA SEQUENCING AND ASSAYS MARKET SNAPSHOT
FIGURE 18 MIRNA SEQUENCING AND ASSAYS MARKET (GLOBAL), COMPETITIVE LEADERSHIP MAPPING, 2017
FIGURE 19 RANK OF COMPANIES IN THE GLOBAL MIRNA SEQUENCING AND ASSAYS MARKET, 2017
FIGURE 20 ILLUMINA: COMPANY SNAPSHOT
FIGURE 21 THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT
FIGURE 22 QIAGEN N.V: COMPANY SNAPSHOT
FIGURE 23 PERKINELMER, INC.: COMPANY SNAPSHOT
FIGURE 24 TAKARA BIO, INC.: COMPANY SNAPSHOT
